CA-IX and HPV as Diagnostic Biomarkers for Cervical Dysplasia in Japanese Women
Author Information
Author(s): Liao S-Y, Rodgers W H, Kauderer J, Bonfiglio T A, Darcy K M, Carter R, Levine L, Spirtos N M, Susumu N, Fujiwara K, Walker J L, Hatae M, Stanbridge E J
Primary Institution: Gynecologic Oncology Group
Hypothesis
The study aims to evaluate the diagnostic utility of carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as biomarkers for cervical dysplasia in women with atypical glandular cells.
Conclusion
The combination of CA-IX and HPV testing improved the diagnostic accuracy for significant cervical lesions.
Supporting Evidence
- 42% of women in the study had significant cervical lesions.
- CA-IX testing alone had a sensitivity of 89% for significant cervical lesions.
- H-HPV testing had a sensitivity of 65% for significant cervical lesions.
- The combination of CA-IX and H-HPV testing had a sensitivity of 97% for significant cervical lesions.
Takeaway
Doctors used two tests to check for serious cervical problems in women with unusual cell results, and found that using both tests together worked best.
Methodology
Immunostaining was used to detect CA-IX in Pap smears, and PCR was used to detect H-HPV in liquid-based cytology specimens.
Potential Biases
The study relied on pathologists' interpretations, which could introduce variability.
Limitations
The study had a relatively low detection rate for H-HPV in significant cervical lesions.
Participant Demographics
All participants were Japanese women aged 29 to 80, with a median age of 46.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website